Navigation Links
Avalon Updates the AVN944 Phase I Hematologic Malignancies Trial

e Trout Group, LLC Fax: (301) 556-9910 Chad Rubin (Investors) Email: Tel: (646) 378-2947 info@avalonrx.com

CONTACT: David D. Muth, Executive Vice President & Chief Business Officer,Avalon Pharmaceuticals, +1-301-556-9900, or fax +1-301-556-9910, Email:; or Media, Wendy Lau, Russo Partners, LLC, +1-212-845-4272; or Investors, Chad Rubin, The Trout Group,LLC, +1-646-378-2947,both for Avalon Pharmaceuticals, Inc. info@avalonrx.com

Web site: http://www.avalonrx.com/

Ticker Symbol: (NASDAQ-NMS:AVRX)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3

Related medicine technology :

1. Avalon Pharmaceuticals Announces Positive Interim Results For AVN944 Phase I Trial
2. Avalon Pharmaceuticals to Present at the American Association for Cancer Research 2007 Annual Meeting
3. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
4. Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing Sustained Safety and Significant Reductions in Repeat Procedures
5. NCCN Updates Esophageal and Gastric Cancer Guidelines
6. Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS 301012 in Familial Hypercholesterolemia Patients
7. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
8. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
9. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Avalon Updates the AVN944 Phase Hematologic Malignancies Trial
(Date:12/1/2008)...swire-FirstCall/ -- Following a,Request for Propo...VA-based,third generation smallpox vaccine, Publ...f of the Canadian Department of National Defence, ... delivery of IMVAMUNE(R). , The Canadian au...,country,s bio-preparedness programme. , T...
(Date:11/30/2008)...- Abnormalities in auditory and language processin...m disorder by using magnetoencephalography (MEG), ... meeting of the Radiological Society of North Amer...he tiny magnetic fields associated with electrical...e chair of research in the Department of Radiology...
(Date:11/26/2008)... and intelligent clinical applications take workfl... , CHICAGO, Ill., Nov. 26 /PRNewswire-FirstC...ealthcare ) highlights the ACUSON S2000(TM) Autom... first multi-use, automated volume breast ultrasou...ual Meeting of the Radiological Society of North A...
(Date:11/25/2008)...ewswire/ -- Proteolix, Inc., a,leader in the disc...arget,protein degradation pathways in cancer and ...om two ongoing Phase 2 clinical trials of carfilzo...upcoming 50th Annual Meeting of the,American Soci... in a new class,of specific proteasome inhibitors...
Breaking Medicine Technology:The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Brain Waves Show Sound Processing Abnormalities in Autistic Children 2Brain Waves Show Sound Processing Abnormalities in Autistic Children 3Siemens Introduces New Standard of Care for Breast Ultrasound 2Siemens Introduces New Standard of Care for Breast Ultrasound 3Siemens Introduces New Standard of Care for Breast Ultrasound 4Siemens Introduces New Standard of Care for Breast Ultrasound 5Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3New HIV Prevention Anti Stigma Campaign Featuring HIV Positive 26 Negative Persons TOGETHER Launches Across the Nation 25536 1New HIV Prevention Anti Stigma Campaign Featuring HIV Positive 26 Negative Persons TOGETHER Launches Across the Nation 25536 2Affitech and Omeros Enter Into Antibody Discovery and Development Agreement 7207 1Affitech and Omeros Enter Into Antibody Discovery and Development Agreement 7207 2Affitech and Omeros Enter Into Antibody Discovery and Development Agreement 7207 3Tadalafil shows promise for relief of lower urinary tract symptoms associated with BPH 25533 1Tadalafil shows promise for relief of lower urinary tract symptoms associated with BPH 25533 2bioMETRX Inc Acquires Assets of Sequiam Biometrics 28Pty 29 Ltd 4517 1bioMETRX Inc Acquires Assets of Sequiam Biometrics 28Pty 29 Ltd 4517 2bioMETRX Inc Acquires Assets of Sequiam Biometrics 28Pty 29 Ltd 4517 3
...alix,Pharmaceuticals, Ltd. (NASDAQ:SLXP) today ann...rials related to the Company,s products,will be pr...ill be,held May 19-24, 2007. Digestive Disease Wee...eeting in the world for the GI,professional. Every...earchers and academics from around the world who d...
... safety and,efficacy of first FDA-approved nebuliz...to severe COPD --, NAPA, Calif., May 16, 2007 /PRN...data presentations will be given at the,Internatio...TS) on,Sunday, May 20, at the Moscone Center in Sa...II clinical data demonstrating the,safety and effi...
Other Medicine Technology:Salix Pharmaceuticals Previews Digestive Disease Week 2007 2Salix Pharmaceuticals Previews Digestive Disease Week 2007 3Salix Pharmaceuticals Previews Digestive Disease Week 2007 4Salix Pharmaceuticals Previews Digestive Disease Week 2007 5Clinical Trial Data for Perforomist Inhalation Solution to be,Presented at ATS on May 20, 2007 2Clinical Trial Data for Perforomist Inhalation Solution to be,Presented at ATS on May 20, 2007 3Clinical Trial Data for Perforomist Inhalation Solution to be,Presented at ATS on May 20, 2007 4
(Date:12/2/2008)...swire/ -- TYRX, Inc., a leader in the development ...oducts, today announced the appointment of David E... for commercial operations. , , Mr. Elliot ...device industry. Mr. Elliot joins TYRX from Valam ...ng laser-based antimicrobial and vascular plaque d...
(Date:12/2/2008)...ire/ -- BioIQ , the leader in consumer-friendly h... , who provides services that include wellness, he... care management as well as case management of acu...ployers, and government agencies, will work togeth...orting tools as part of Alere,s Personal Health So...
(Date:12/2/2008)...s form an integral part of most of,original equip...fore become,essential for service providers in th...ain competitive and constantly improve their servi...o: http://www.newscom.com/cgi-bin/prnh/20081117/...llivan ( http://www.medicalimaging.frost.com ),Eu...
(Date:12/2/2008)...lect and disseminate pharmacy experience and knowl...(PRWEB) December 2, 2008 -- Pharmacy OneSource, I...e to focus public and industry attention on medic...SPEAK will occur during the American Society of He...al Meeting, to be held December 7-11 in Orlando, F...
Breaking Medicine News(10 mins):Health News:TYRX Appoints David Elliot, Jr. Chief Operating Officer 2Health News:TYRX Appoints David Elliot, Jr. Chief Operating Officer 3Health News:BioIQ and Alere to Provide At-Home Biometric Screening Tests to Employees 2Health News:Encouraging Prospects for Medical Imaging Equipment Services in Europe 2Health News:Encouraging Prospects for Medical Imaging Equipment Services in Europe 3Health News:Pharmacy OneSource Launches SPEAK Initiative to Promote Medication Safety Awareness 2
...ts in Britain have said that The World Bank did no...bly to keep up the promised sum of $500 million// ...o have manipulated data, with no adequate infrastr... of such a magnitude, reach completion. It is also...
...orities have declared that they will be launching ...curb infant and child deaths. This emergency vacci... and aims to protect nearly thousands of children ...s and five years. Nearly 1,600 cases of measles h...
...y done on 179 stroke patients, it was found that t... damage when they had stroke. The three drug// a c...tor for blood pressure control, and a cholesterol-...rk synergistically to reduce the amount of brain t...
... suggested that women who drink insufficient milk ...due to concerns about allergies may inhibit// thei...study were pubished in the Canadian Medical Associ...e study. All were non-smokers. However, on compari...
Other Medicine News:Health News:Limiting milk can hamper Babies’ Growt 2
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
Medicine Products: